Table 2.
Summary of multivariate analysis of prognostic factors
| Factors | B | p-value | Exp (B) | Exp (B) (95% CI) | |
|---|---|---|---|---|---|
| LCS | T category | 2.298 | 0.005 | 9.959 | 1.977 - 50.169 |
| N category | 1.460 | 0.042 | 0.232 | 0.057 - 0.949 | |
| 3D-BT vs. 2D-BT | NS | ||||
| DFS | T category | 0.973 | 0.031 | 2.647 | 1.093 - 6.407 |
| N category | 2.950 | < 0.001 | 19.113 | 5.621 - 64.997 | |
| 3D-BT vs. 2D-BT | NS | ||||
| OS | T category | NS | |||
| N category | 2.625 | < 0.001 | 13.800 | 4.128 - 46.127 | |
| 3D-BT vs. 2D-BT | NS | ||||
| LRFS | T category | 1.407 | 0.025 | 4.083 | 1.192 - 13.989 |
| N category | NS | ||||
| 3D-BT vs. 2D-BT | NS | ||||
| CSS | T category | NS | |||
| N category | 3.106 | < 0.001 | 22.324 | 6.073 - 82.067 | |
| 3D-BT vs. 2D-BT | NS | ||||
| DMFS | T category | NS | |||
| N category | 4.043 | < 0.001 | 57.020 | 9.307 - 349.347 | |
| 3D-BT vs. 2D-BT | NS |
Abbreviations: CI, confidence interval; 2D-BT, two-dimensional high-dose-rate brachytherapy; 3D-BT, three-dimensional high-dose-rate brachytherapy; NS, not significant.